Multibagger Stocks: The shares of Indian pharmaceutical company Sun Pharmaceutical Industries Limited have given bumper returns of more than 39,000 per cent to its investors in the last 23 years. Sun Pharma shares suggest that if investors invest in the right company for long term and maintain their investments with patience, they can earn profits of crores by investing few thousand or lakhs.
Shares of Sun Pharma closed at Rs 896.70 per share on NSE on Tuesday, October 27. However, 23 years ago on January 1, 1999, when Sun Pharma’s shares started trading for the first time on NSE, its effective price was just Rs 2.27, which has now increased by about 39,402 percent to Rs 896.70.
This means that if an investor had invested Rs 1 lakh in the shares of Sun Pharma 23 years ago on January 1, 1999 and had maintained that investment till today, then today the value of his Rs 1 lakh would have increased to about 3.95 crores. Would have been Rs. Similarly, if an investment had put only 30 thousand rupees in Sun Pharma shares 23 years ago, today its value of 30 thousand rupees would have increased to 1 crore 18 lakh rupees and today she would have been a millionaire.
Also read- Indraprastha Gas shares climb 7% in one day, prepare for 275% dividend payment, should you invest?
Talking about the recent performance of Sun Pharma’s stock, the company’s shares have gained about 1.98 percent in the last one month. Whereas in the last one year, its price has increased by about 15.69 percent. At the same time, it has given a return of 78.18 percent to its investors in the last one year.
What is the expert’s opinion on the stock?
Angel One analyst Osho Krishnan recently expressed a positive attitude towards Sun Pharma’s stock and said that in the next 2-3 weeks, these stocks can earn good earnings. “Sun Pharmaceutical Industries has shown strong momentum from the recent low of Rs 856. The stock is currently well above all its Major Exponential Moving Averages on the Daily Chart,” he added.
“Meanwhile, the stock remains on a positive note. On the technical front too, the 14-period RSI (Relative Strength Index) is in the comfort zone after a positive crossover. This indicates a continuation of momentum in the near term,” he added. So, we recommend Buying this stock with a target price of Rs 992 with a stop loss of Rs 874.”
Company’s financial health?
Sun Pharmaceutical’s consolidated profit for the June quarter jumped 43 per cent to Rs 2,061 crore, from Rs 1,444 crore in the year-ago quarter. The company’s consolidated income grew 10.7 per cent to Rs 10,762 crore as against Rs 9,719 crore in the year-ago quarter.
Disclaimer: The information provided here is given on the basis of share performance. It is important to mention that investing in the market is subject to market risks. Always consult an expert before investing money as an investor. It is never advised to invest money here on behalf of Moneycontrol.